Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Albuminuria Reduction Trial and Investigation With Survodutide Treatment in CKD

NCT07206290 is registered in ClinicalTrials.gov with University Medical Center Groningen as lead sponsor.

NCT NCT07206290
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07206290 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Albuminuria Reduction Trial and Investigation With Survodutide Treatment in CKD
Lead sponsor
University Medical Center Groningen
Phase
Phase 2
Overall status
Not yet recruiting
Start date
March 2, 2026
Completion date
November 30, 2027
Enrollment
120 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

chronic kidney disease